Impact Of Promising Alzheimer’s Drug Could Be ‘Enormous’
The new drug is currently in a phase-three clinical study, but if it is found to be effective, it could stop the advance of Alzheimer's in patients, said Dr. Keith Fargo, director of scientific programs for the Alzheimer’s Association.
Ventura County Star:
Alzheimer's Breakthrough Is Coming, Says Expert
If drugs that could become available within three years work as designed, there could be nearly 500,000 fewer cases of Alzheimer’s disease each year, an Alzheimer’s Association scientist said Thursday in Oxnard. "It would change everything,” said Dr. Keith Fargo, director of scientific programs for the association. “If this works, the impact would be enormous.” Speaking between sessions of an Oxnard conference aimed at professional caregivers and others, Fargo cited the roughly 50 Alzheimer’s drugs in clinical studies. Many are designed to take the leap and stop the progression of the disease in its early stages. (Kisken, 6/14)